Literature DB >> 17877725

Clinicopathological and prognostic features of primary clear cell carcinoma of the liver.

Zhisheng Liu1, Weidong Ma, Huikai Li, Qiang Li.   

Abstract

AIM: Primary clear cell carcinoma of the liver (PCCCL) is a subgroup of primary hepatocellular carcinoma (HCC), pathologically characterized by diffuse clear cells of the tumor, showing a clear cytoplasm that does not stain with hematoxylin-eosin. At present, its clinicopathological and prognostic features are not fully clarified. This study aims to clarify the clinicopathological and prognostic features of PCCCL.
METHODS: The clinicopathological data of 43 patients with PCCCL treated with hepatectomy in our hospital from January 1999 to December 2003 were retrospectively analyzed.
RESULTS: The chi(2)-test showed a positive rate of hepatitis C virus (HCV) infection and capsule formation in the PCCCL group, which was markedly higher than in the common type HCC (CHCC) group (P = 0.000 and P = 0.005). Meanwhile, the vascular invasion rate was notably lower in the PCCCL group, but there were no significant differences between the twogroups (P = 0.129). The Kaplan-Meier method showed that the 1-, 3-, and 5-year survival rates were significantly higher in the PCCCL group than in the CHCC group (P = 0.021). The prognosis of patients in the PCCCL group was related to capsule formation, vascular invasion, liver cirrhosis, and clear cell ratio. The 1-, 3-, and 5-year survival rates were markedly higher in the group with a higher clear cell ratio than in the group with a lower clear cell ratio (P = 0.011).
CONCLUSION: The notable clinicopathological features of the patients in the PCCCL group included a higher rate of HCV infection, capsule formation, and a lower rate of vascular invasion. The prognosis was better than that of the patients in the CHCC group and related to the ratio of clear cells.

Entities:  

Year:  2007        PMID: 17877725     DOI: 10.1111/j.1872-034X.2007.00264.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  16 in total

1.  Clear Cell Cancer of the Liver Presenting with Pathological Humeral Fracture: a Case Report.

Authors:  Mina S Hanna; Debasish Das
Journal:  J Gastrointest Cancer       Date:  2015-12

2.  Metastatic hepatic clear cell carcinoma presenting as lump in the hilum of the lung: a case report and review of the literature.

Authors:  Qiufen Xun; Yuanyuan Li; Huaping Yang; Jingxia Li; Chengping Hu
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

3.  Primary clear cell carcinoma in the liver: CT and MRI findings.

Authors:  Qing-Yu Liu; Hai-Gang Li; Ming Gao; Xiao-Feng Lin; Yong Li; Jian-Yu Chen
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

4.  Liver transplantation and cirrhotomimetic hepatocellular carcinoma: classification and outcomes.

Authors:  Erica F Clayton; Saloni Malik; Alexander Bonnel; Yifei Mu; Kim Olthoff; Abraham Shaked; Peter L Abt; Heather Peterman; K Rajender Reddy; Shane Ottmann; Emma E Furth; Matthew H Levine
Journal:  Liver Transpl       Date:  2014-05-26       Impact factor: 5.799

5.  A case of primary clear cell hepatocellular carcinoma in a non-cirrhotic liver: an immunohistochemical and ultrastructural study.

Authors:  Erica Fan Clayton; Emma Elizabeth Furth; Amy Ziober; Theodore Xu; Yuan Yao; Pil Gyu Hwang; Zhanyong Bing
Journal:  Rare Tumors       Date:  2012-05-17

Review 6.  Primary Clear Cell Carcinoma of the Non-cirrhotic Liver Presenting as an Acute Abdomen: a Case Report and Review of the Literature.

Authors:  Jiten P Kothadia; Navneet Kaur; Rezina Arju; Mahmoud Dakhel; Shah Giashuddin
Journal:  J Gastrointest Cancer       Date:  2017-06

7.  Hand-assisted laparoscopic hepatectomy for primary clear cell hepatocellular carcinoma of the liver.

Authors:  Kazutoshi Kida; Takatsugu Oida; Kenji Mimatsu; Hisao Kano; Atsushi Kawasaki; Nobutada Fukino; Youichi Kuboi
Journal:  Case Rep Gastroenterol       Date:  2012-05-30

Review 8.  Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.

Authors:  Michael S Torbenson
Journal:  Hum Pathol       Date:  2020-12-30       Impact factor: 3.526

9.  Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation.

Authors:  Huan Tong; Xiao Li; Chun-LE Zhang; Jin-Hang Gao; Shi-Lei Wen; Zhi-Yin Huang; Cheng-Wei Tang
Journal:  Exp Ther Med       Date:  2013-01-16       Impact factor: 2.447

10.  Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy.

Authors:  Zu-Shun Chen; Shao-Liang Zhu; Lu-Nan Qi; Le-Qun Li
Journal:  Onco Targets Ther       Date:  2016-07-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.